Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Donepezil and EGb761 may be effective in improving neurocognitive function (such
as thinking, attention, concentration, and memory) and may improve quality of life in
patients who have undergone radiation therapy to the brain.
PURPOSE: This phase II trial is studying how well donepezil or EGb761 works in improving
neurocognitive function in patients who have undergone radiation therapy for primary brain
tumor or brain metastases.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences